Integer Holdings Net Profit Margin 2010-2022 | ITGR

Integer Holdings net profit margin from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Integer Holdings Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $1.24B $0.09B 6.92%
2021-12-31 $1.22B $0.10B 7.94%
2021-09-30 $1.18B $0.09B 7.48%
2021-06-30 $1.11B $0.10B 8.67%
2021-03-31 $1.04B $0.07B 6.47%
2020-12-31 $1.07B $0.08B 7.08%
2020-09-30 $1.13B $0.07B 6.37%
2020-06-30 $1.20B $0.07B 6.09%
2020-03-31 $1.27B $0.11B 8.33%
2019-12-31 $1.26B $0.10B 7.70%
2019-09-30 $1.24B $0.11B 9.06%
2019-06-30 $1.24B $0.20B 15.76%
2019-03-31 $1.24B $0.18B 14.71%
2018-12-31 $1.21B $0.17B 13.84%
2018-09-30 $1.14B $0.20B 17.27%
2018-06-30 $1.12B $0.10B 8.60%
2018-03-31 $1.08B $0.08B 7.29%
2017-12-31 $1.14B $0.07B 5.90%
2017-09-30 $0.96B $0.02B 2.19%
2017-06-30 $1.02B $0.02B 1.76%
2017-03-31 $1.09B $0.01B 1.29%
2016-12-31 $1.08B $0.01B 0.47%
2016-09-30 $1.35B $-0.03B -2.08%
2016-06-30 $1.15B $-0.04B -3.41%
2016-03-31 $0.97B $-0.03B -2.98%
2015-12-31 $0.80B $-0.01B -1.00%
2015-09-30 $0.65B $0.03B 4.75%
2015-06-30 $0.68B $0.05B 6.64%
2015-03-31 $0.68B $0.05B 7.11%
2014-12-31 $0.69B $0.06B 7.99%
2014-09-30 $0.70B $0.05B 7.34%
2014-06-30 $0.69B $0.05B 6.95%
2014-03-31 $0.69B $0.05B 6.67%
2013-12-31 $0.66B $0.04B 5.57%
2013-09-30 $0.65B $0.02B 3.25%
2013-06-30 $0.64B $0.00B 0.31%
2013-03-31 $0.64B $-0.00B -0.63%
2012-12-31 $0.65B $-0.01B -0.93%
2012-09-30 $0.63B $0.01B 0.95%
2012-06-30 $0.60B $0.02B 3.50%
2012-03-31 $0.58B $0.03B 4.48%
2011-12-31 $0.57B $0.03B 5.96%
2011-09-30 $0.56B $0.04B 7.49%
2011-06-30 $0.56B $0.04B 7.37%
2011-03-31 $0.55B $0.04B 7.27%
2010-12-31 $0.53B $0.03B 6.38%
2010-09-30 $0.53B $0.02B 3.42%
2010-06-30 $0.52B $-0.01B -1.73%
2010-03-31 $0.51B $-0.01B -1.95%
2009-12-31 $0.52B $-0.01B -1.72%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.471B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.239B 21.56
Edwards Lifesciences (EW) United States $58.078B 40.79
STERIS (STE) Ireland $21.939B 27.70
Fresenius Medical Care AG KGaA (FMS) Germany $17.187B 15.44
Teleflex (TFX) United States $13.429B 21.47
Globus Medical (GMED) United States $6.674B 33.36
Penumbra (PEN) United States $5.445B 344.07
Glaukos (GKOS) United States $1.852B 0.00
Nevro (NVRO) United States $1.570B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.326B 23.75
Paragon 28 (FNA) United States $1.161B 0.00
Artivion (AORT) United States $0.743B 80.35
Alcon (ALC) Switzerland $0.000B 30.18